sulfasalazine tablet
bryant ranch prepack - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.
ratio-sulfasalazine en tablet (enteric-coated)
ratiopharm inc division of teva canada limited - sulfasalazine - tablet (enteric-coated) - 500mg - sulfasalazine 500mg - sulfonamides
ratio-sulfasalazine tab 500mg tablet
ratiopharm inc division of teva canada limited - sulfasalazine - tablet - 500mg - sulfasalazine 500mg - sulfonamides
salazopyrin-en
pfizer new zealand limited - sulfasalazine 500mg (sulfasalazine 500 mg added as 535 mg sulfasalazine with povidone) - enteric coated tablet - 500 mg - active: sulfasalazine 500mg (sulfasalazine 500 mg added as 535 mg sulfasalazine with povidone) excipient: carnauba wax cellacefate colloidal silicon dioxide macrogol 20000 magnesium stearate povidone propylene glycol purified talc self-emulsifying glyceryl monostearate starch white beeswax - ulcerative colitis and crohn's disease adjunct in the treatment of ulcerative colitis with the usual supportive and dietary measures. for the management of severe, acute attacks of ulcerative colitis, rectal and systemic corticosteroid therapy appears to be clinically superior to sulfasalazine, but sulfasalazine may be more effective than corticosteroids in reducing the number of relapses in patients on maintenance therapy. in the treatment of active crohn's disease, especially in patients with colonic involvement. rheumatoid arthritis salazopyrin en tablets are indicated for rheumatoid arthritis which has failed to respond to nonsteroidal anti-inflammatory drugs (nsaids).
sulfasalazine 500mg gastro-resistant tablets
a a h pharmaceuticals ltd - sulfasalazine - gastro-resistant tablet - 500mg
sulfasalazine 500mg gastro-resistant tablets
accord-uk ltd - sulfasalazine - gastro-resistant tablet - 500mg
sulfasalazine 500mg gastro-resistant tablets
kent pharma (uk) ltd - sulfasalazine - gastro-resistant tablet - 500mg
sulfasalazine 500mg gastro-resistant tablets
alliance healthcare (distribution) ltd - sulfasalazine - gastro-resistant tablet - 500mg
sulfasalazine 500mg tablets
a a h pharmaceuticals ltd - sulfasalazine - oral tablet - 500mg
sulfasalazine 500mg tablets
actavis uk ltd - sulfasalazine - oral tablet - 500mg